M8 Ventures
VC Fund
Sydney, Australia
M8 Ventures is a small, fast, pre-seed specialist venture fund focusing on the earliest stages of investment in the next generation of successful global tech companies from Australia and New Zealand. The firm was founded in 2018 and based in Sydney, New South Wales, Australia.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 42%
Last updated:
For AI agents: llms.txt
Industries M8 Ventures invests in
Stages M8 Ventures invests in
Countries M8 Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.4M–$8M
- Pre-Seed
- $200k–$1M
Investment Focus
Industry
- Health Care 2 (17%)
- B2B 1 (8%)
- SaaS 1 (8%)
- Medical 1 (8%)
- Internet 1 (8%)
Stage
- Seed 5 (42%)
- Pre-Seed 4 (33%)
- Series A 1 (8%)
Country
- Australia 6 (50%)
- United States 2 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Emily Rich
Partner
|
Partner | Total investments: 4 | Find email | |
Alan Jones
General Partner
|
General Partner | Total investments: 7 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Elita platform combines dog stem cells with health data to help predict, prevent, and treat disease before symptoms appear. | $1.4M / Seed / Sep 14, 2026 | ||
| Emanda App helps business advisory firms and companies determine business value, auto-generate data rooms, set goals, and track progress daily via AI-driven tools. | $199.7K / Pre-Seed / Dec 12, 2025 | ||
| At Hola, we’re creating the future of healthcare. Connecting patients, practitioners and pharmacies to deliver more timely & convenient access to care that we call ‘on-demand healthcare’. | $3.6M / Series A / Apr 08, 2025 | ||
| Flowing Bee is a trailblazing SaaS startup revolutionising the way businesses understand and engage with their audiences. By blending cutting-edge AI with the principles of behavioural science, we empower marketing teams to unlock deep psychological insights and craft campaigns that drive real, measurable results.The Flowing Bee platformenables businesses to conduct behavioural studies, uncovering the “why” behind consumer decisions. From optimising marketing comms, to designing high-impact strategies, we help our clients stretch their marketing budgets and achieve their goals with precision and creativity.In the short time Flowing Bee has been operating, we have secured investment from some of Australia’s largest and most reputable VC firms, and have brought on ASX-listed customers across the retail, healthcare and financial services sectors | $1M / Pre-Seed / Feb 05, 2025 | ||
| Elita platform combines dog stem cells with health data to help predict, prevent, and treat disease before symptoms appear. | $680.9K / Pre-Seed / Jan 17, 2025 | ||
| BindiMaps is a mobile app that locates users precisely in indoor spaces. It uses a simple, natural language audio system to describe where users are and what’s around them, and the best way to get to their chosen destination.Our Mission is to make every indoor space 100% accessible, changing the lives of people with vision impairment and makingunfamiliar spaces easier and more efficient for everyone to navigate. | Seed / Nov 20, 2024 | ||
| Preplocal is a B2B food distribution platform that specializes in the distribution of both dry and temperature-controlled goods. | Seed / Nov 20, 2024 | ||
| SeenCulture creates personalized Employee Experiences enabling people to feel seen beyond their job title, for their strengths, values, and lifestyles. | $1M / Pre-Seed / Jul 20, 2024 | ||
| Xylo Bio is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications. | $8M / Seed / Jun 02, 2024 | ||
| At Hola, we’re creating the future of healthcare. Connecting patients, practitioners and pharmacies to deliver more timely & convenient access to care that we call ‘on-demand healthcare’. | $2.9M / Seed / Mar 19, 2024 | ||
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does M8 Ventures invest in?
M8 Ventures invests primarily in Health Care, B2B and SaaS startups, most often at Seed and Pre-Seed stage. Most of the 12 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is M8 Ventures's check size?
M8 Ventures typically joins rounds of $1.4M–$8M at Seed and $200k–$1M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds M8 Ventures participates in.
How do I contact M8 Ventures?
Public channels for M8 Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at M8 Ventures?
The team at M8 Ventures includes Emily Rich (Partner) and Alan Jones (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
